CD34 Immunophenotyping of Blasts in Myelodysplasia

References

• Bennett J.M., Catovsky D., Daniel M.T., Flandrin G., Galton D. A. G., Gralnick H.R., Sultan C. Proposals for the classification of the myelodysplastic syndromes. Br. J. Haematol. 1982; 51: 189–199
   PubMed Web of Science ®Google Scholar
• Kantarjian H.M., Shtalrid M., Kurzrock R., Blick M., Dalton W.T., Le Maistre A., Stass S.A., McCredie K.B., Gutterman J., Freireich E.J., Talpaz M. Significance and correlations of molecular analysis results in patients with Philadelphia chromosome-negative chronic myelogenous leukemia and chronic myelomonocytic leukemia. Am. J. Med. 1988; 85: 639–644
   PubMed Web of Science ®Google Scholar
• Storniolo A.M., Moloney W.C., Rosenthal D.S., Cox C., Bennett J.M. Chronic myelomonocytic leukemia. Leukemia 1990; 4: 766–770
   PubMed Web of Science ®Google Scholar
• Fenaux P., Jouet J.P., Zandecki M., Lai J.L., Simon M., Pollet J.P., Bauters F. Chronic and subacute myelomonocytic leukemia in the adult: A report of 60 cases with special reference to prognostic factors. Br. J. Haematol. 1987; 65: 101–106
   PubMed Web of Science ®Google Scholar
• Worsley A., Oscier D.G., Stevens J., Darlow S., Figes A., Mufti G.J., Hamblin T.J. Prognostic features of chronic myelomonocytic leukaemia: A modified Bournemouth score gives the best prediction of survival. Br. J. Haematol. 1988; 68: 17–21
   PubMed Web of Science ®Google Scholar
• Goasguen J.E., Bennett J.M., Cox C., Hambley H., Mufti G., Flandrin G. Prognostic implication and characterization of the blast cell population in the myelodysplastic syndrome. Leuk. Res. 1991; 15: 1159–1165
   PubMed Web of Science ®Google Scholar
• Mufti G.J., Stevens J.R., Oscier D.G., Hamblin T.J., Machin D. Myelodysplastic syndromes: a scoring system with prognostic significance. Br. J. Haematol. 1985; 59: 425–433
   PubMed Web of Science ®Google Scholar
• Sanz G.F., Sanz M.A., Vallespi T., Canizo M.C., Tor-Rabadella M., Garcia S., Irriguible D., San Miguel J.F. Two regression models and a scoring system for predicting survival and planning treatment in myelodysplastic syndromes: a multivariate analysis of prognostic factors in 370 patients. Blood 1989; 74: 395–408
   PubMed Web of Science ®Google Scholar
• Aul C., Gattermann N., Heyll A., Germing U., Derigs G., Schneider W. Primary myelodysplastic syndromes: analysis of prognostic factors in 235 patients and proposals for an improved scoring system. Leukemia 1992; 6: 52–59
   PubMed Web of Science ®Google Scholar
• Civin C.I., Strauss L.C., Brovall C., Fackler M.J., Schwartz J.F., Shaper J.H. Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-la cells. J. Immunol. 1984; 133: 157–165
   PubMed Web of Science ®Google Scholar
• Strauss L.C., Rowley S.D., La Russa V.F., Sharkis S.J., Stuart R.K., Civin C.J. Antigenic analysis of hematopoiesis. V. Characterization of My-10 antigen expression by normal lymphohematopoietic progenitor cells. Exp. Hematol. 1986; 14: 878–886
   PubMed Web of Science ®Google Scholar
• Civin C.I., Banquerigo M.L., Strauss L.C., Loken M.R. Antigenic analysis of hematopoiesis. VI. Flow cytometric characterization of My-10-positive progenitor cells in normal human bone marrow. Exp. Hematol. 1987; 15: 10–17
   PubMed Web of Science ®Google Scholar
• Pierelli L., Teofili L., Menichella G., Rumi C., Paoloni A., Iovino S., Puggioni P.L., Leone G., Bizzi B. Further investigations on the expression of HLA-DR, CD33 and CD 13 surface antigens in purified bone marrow and peripheral blood CD34+ haematopoietic cells. Br. J. Haematol. 1993; 84: 24–30
   PubMed Web of Science ®Google Scholar
• Andrews R.G., Singer J.W., Bernstein I.D. Precursors of colony forming cells in human can be distinguished from colony-forming cells by expression of the CD33 and CD34 antigens and light scatter properties. J. Exp. Med. 1989; 169: 1721–1731
   PubMed Web of Science ®Google Scholar
• Strobl H., Takimoto M., Majdic O., Höcker P., Knapp W. Antigenic analysis of human haematopoietic progenitor cells expressing the growth factor receptor c-kit. Br. J. Haematol. 1992; 82: 287–294
   PubMed Web of Science ®Google Scholar
• Sutherland H.J., Eaves C.J., Eaves A.C., Dragowska W., Lansdorp P.M. Characterization and partial purification of human marrow cells capable of initiating long-term hematopoiesis in vitro. Blood 1989; 74: 1563–1570
   PubMed Web of Science ®Google Scholar
• Baum C.M., Weissmann I.L., Tsukamoto A.S., Buckle A.M., Peault B. Isolation of a candidate human hematopoietic stem-cell population. Proc. Natl. Acad. Sci. USA 1992; 89: 2804–2810
   PubMed Web of Science ®Google Scholar
• Cambareri A.C., Ashman L.K., Cole S.R., Lyons A.B. A monoclonal antibody to a human mast cell/myeloid leukaemia specific antigen binds to normal haematopoietic progenitor cells and inhibits colony formation in vitro. Leuk. Res. 1988; 12: 929–939
   PubMed Web of Science ®Google Scholar
• Lerner N.B., Nocka K.H., Cole S.R., Qui F., Strife A., Ashman L.K., Besmer P. Monoclonal antibody YB5.B8 identifies the human c-kit protein product. Blood 1991; 77: 1876–1883
   PubMed Web of Science ®Google Scholar
• Reisbach G., Bartke I., Kempkes B., Kostka G., Ellwart J., Birner A., Thalmeier K., Mailhammer R., Bornkamm G.W., Ullrich A., Dormer P. Characterization of hemopoietic cell populations from human cord blood expressing c-kit. Exp. Hematol. 1993; 21: 74–79
   PubMed Web of Science ®Google Scholar
• Erber W.N., Breton-Gorius J., Villeval J.L., Oscier D.G., Bai Y., Mason D.Y. Detection of cells of megakaryocyte lineage in haematological malignancies by immuno-alkaline phosphatase labelling cell smears with a panel of monoclonal antibodies. Br. J. Haematol. 1987; 9: 781–787
   Google Scholar
• Oertel J., Oertel B., Beyer J., Huhn D. CD34 immunotyping of blasts in myelodysplasia. Ann. Hematol. 1994; 2: 77–80
   Web of Science ®Google Scholar
• Guyotat D., Campos L., Thomas X., Villa L., Shi Z.H., Charrin C., Gentihomme O., Fiere D. Myelodysplastic syndromes: a study of surface markers and in vitro growth pattern. Am. J. Hematol. 1990; 34: 26–31
   PubMed Web of Science ®Google Scholar
• Kristensen J.S., Hokland P. Monoclonal antibody ratios in malignant myeloid diseases: diagnostic and prognostic use in myelodysplastic syndromes. Br. J. Haematol. 1990; 74: 270–276
   PubMed Web of Science ®Google Scholar
• List A.S., Spier C.M., Cline A., Doll D., Garwal H. Expression of the multidrug resistance gene product (P-glycoprotein) in myelodysplasia is associated with stem cell phenotype. Br. H. Haematol. 1991; 78: 28–34
   PubMed Web of Science ®Google Scholar
• Sullivan S.A., Marsden K.A., Lowenthal R.M., Jupe D.M., Jones M.E. Circulating CD34+ cells: an adverse prognostic factor in the myelodysplastic syndromes. Am. J. Hematol. 1992; 39: 96–101
   PubMed Web of Science ®Google Scholar
• Oertel J., Kleiner S., Huhn D. Immunotyping of blasts in refractory anaemia with excess of blasts. Br. J. Haematol. 1992; 84: 305–309
   Web of Science ®Google Scholar
• San Miguel J.F., Hernandez J.M., Gonzalez-Sarmiento R., Gonzalez M., Sanchez I., Canizo O. M. C. Acute leukemia after a primary myelodysplastic syndrome: immunophenotypic, genotypic, and clinical characteristics. Blood 1991; 78: 768–776
   PubMed Web of Science ®Google Scholar
• Masuya M.M., Kita K., Shimizu N., Ohishi K., Katayama N., Sekine T., Miwa A., Otsuji H., Shirakawa S. Biologic characteristics of acute leukemia after myelodysplastic syndrome. Blood 1993; 81: 3388–3394
   PubMed Web of Science ®Google Scholar
• Tricot G., Boogaerts M.A., De Wolf-Peeters C., van den Berghe H., Verwilgen R.L. The myelodysplastic syndrome: different evolution patterns based on sequential morphological and cytogenetic investigations. Br. J. Haematol. 1985; 59: 659–670
   PubMed Web of Science ®Google Scholar
• Bar-Eli M., Ahuja H., Gonzalez-Cadavi A., Cline M.J. Analysis of N-RAS Exon-1 mutations in myelodysplastic syndromes by polymerase chain reaction and direct sequencing. Blood 1989; 73: 281–283
   PubMed Web of Science ®Google Scholar
• Padua R.A., Carter G., Hughes D., Gow J., Farr C., Oscier D., McCormick F., Jacobs A. RAS mutations in myelodysplasia detected by amplification oligonuceotide hybridization and transformation. Leukemia 1988; 2: 503–510
   PubMed Web of Science ®Google Scholar
• Bartram C.R. Molecular genetic aspects of myelodysplastic syndromes. Hematol./Oncol. Clin. N. Am. 1992; 6: 557–570
   PubMed Web of Science ®Google Scholar